Skip to main content
Commentary

Improving the approach to defining, classifying, reporting and monitoring adverse events in seriously ill older adults: recommendations from a multi-stakeholder convening.

Baim-Lance A, Ferreira KB, Cohen HJ, et al. Improving the approach to defining, classifying, reporting and monitoring adverse events in seriously ill older adults: recommendations from a multi-stakeholder convening. J Gen Intern Med. Epub 2022 May 17. doi: 10.1007/s11606-022-07646-7

Save
Print
June 15, 2022
Baim-Lance A, Ferreira KB, Cohen HJ, et al. J Gen Intern Med. 2022;Epub May 17.

When serious adverse events such as death are reported, they are typically associated with poor patient safety. In some fields of care, however, such as palliative care, deaths are expected and not necessarily an indicator of poor quality. This commentary describes how serious and non-serious adverse events (SAEs/AEs) are currently defined and reported, the associated challenges, and proposes a new approach to reporting SAE/AE in clinical trials. A decision-tree to determine SAE/AE reporting based on the new proposed approach is presented.

Save
Print
Cite
Citation

Baim-Lance A, Ferreira KB, Cohen HJ, et al. Improving the approach to defining, classifying, reporting and monitoring adverse events in seriously ill older adults: recommendations from a multi-stakeholder convening. J Gen Intern Med. Epub 2022 May 17. doi: 10.1007/s11606-022-07646-7